Sitagliptin functions by inhibiting the dipeptidyl peptidase-4 enzyme. This action ensures that incretin hormones remain active longer, providing effective glycemic regulation and balancing blood sugar levels after carbohydrate intake.
Sitagliptin is an active pharmaceutical ingredient belonging to a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. It is a therapeutic compound primarily used in the management of type 2 diabetes mellitus. This substance works by helping to regulate blood sugar levels in adults. It is the core active ingredient found in various diabetes medications, often used when diet and exercise alone do not provide sufficient glycemic control.
In Singapore, medications containing sitagliptin are available as oral tablets. These formulations may be used as a single active ingredient or in combination with other diabetes medications, such as metformin, to provide a comprehensive approach to blood sugar management. Patients will find both brand-name and generic versions of these medicines. The specific formulation, strength, and combination product are determined based on individual treatment needs and should be discussed with a healthcare professional.
This DPP-4 inhibitor is utilized to address elevated blood sugar levels in adults diagnosed with type 2 diabetes. Its primary function is to improve glycemic control. It is often considered when first-line treatments, like metformin, are insufficient or not tolerated. The medication assists the body in its own insulin production in response to meals, helping to lower blood sugar after eating. It is a pharmacological option for long-term management of the condition.
Sitagliptin works by targeting a specific enzyme in the body called DPP-4. By inhibiting this enzyme, it increases the levels of certain natural substances known as incretin hormones. These hormones are released in the gut after eating and perform two key functions: they stimulate the pancreas to produce more insulin when blood sugar is high, and they reduce the amount of sugar made by the liver. This combined action helps to normalize blood sugar levels throughout the day.
Individuals taking sitagliptin-containing medications may experience some mild, often transient, reactions. These can include symptoms like a stuffy or runny nose, sore throat, headache, or stomach discomfort such as nausea or diarrhea. These effects are typically not severe and may lessen as the body adjusts to the medication.
While less common, more serious reactions have been reported. It is important to be aware of signs such as severe and persistent joint pain, symptoms of pancreatitis (like severe abdominal pain that may radiate to the back, with or without vomiting), or signs of a serious allergic reaction (including rash, itching, swelling, severe dizziness, or trouble breathing). Experiencing any of these requires immediate medical attention.
This class of medication is not suitable for everyone. It is not indicated for the treatment of type 1 diabetes or diabetic ketoacidosis. Patients with a known hypersensitivity to sitagliptin or any of the tablet's components should avoid its use. Caution is also advised in individuals with a history of pancreatitis or severe kidney impairment, as dosage adjustments may be necessary.
Sitagliptin may interact with other medications. It is particularly important to be aware of potential interactions with other drugs that affect blood sugar levels, including insulin or sulfonylureas, as this could increase the risk of hypoglycemia (low blood sugar). Patients should always provide their healthcare provider with a complete list of all other medicines, supplements, and herbal products they are taking.
For optimal results, this medication is usually part of a treatment plan that includes a balanced diet and regular physical activity. It is typically prescribed for long-term, daily use to manage a chronic condition. The tablets are generally taken orally, once daily, with or without food. Storage should be at room temperature, away from moisture and heat. It is crucial to understand that different branded or generic medications containing sitagliptin may have specific usage instructions.
For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article provides an educational overview of sitagliptin as an active pharmaceutical ingredient and is not a substitute for professional medical advice. Medicines containing sitagliptin, whether as a single agent or in combination, can differ in their formulation, strength, and precise administration guidelines. The information presented here does not constitute a recommendation for any specific clinical application or treatment regimen. Patients should always consult the official product information for their particular medication and seek personalized guidance from a qualified healthcare professional in Singapore for their individual health circumstances.
